Search For "remdesivir"
Glenmark, Cipla stocks surge after nod to launch drugs for mild-to
Updated : 9 months, 3 weeks ago IST
Mumbai (Maharashtra) [India], June 22 (ANI): Glenmark Pharmaceuticals' share price surged 30 per cent on Monday to Rs 531.80 per unit after it became the first pharmaceutical company in India to receive regulatory approval to make and sell oral antiviral drug favipiravir for treating mild-to
Read More
Domestic pharma giants-- Cipla, Hetero got DCGI's nod to manufactu
Updated : 9 months, 4 weeks ago IST
New Delhi [India], June 21 (ANI): In a significant development, India's top drug regulator has given nod to two domestic pharmaceutical companies--Cipla and Hetero for marketing authorization of anti-viral drug Remdesivir only for "restricted emergency use" on COVID-19 patients with moderate
Read More
Six Indian companies applied to CDSCO for permission to manufactur
Updated : 10 months ago IST
New Delhi [India], June 14 (ANI): The Centre on Sunday said that six Indian companies -- Hetero, Cipla, BDR, Jubilant, Mylan and Dr Reddy's Labs -- have applied to Indian Drug Regulatory Agency, Central Drug Standard Control Organisation (CDSCO) for permission to manufacture and market the R
Read More
Remdesivir included in 'investigational therapy' for restricted em
Updated : 10 months ago IST
New Delhi [India], June 14 (ANI): Union Health Ministry on Sunday said that drug Remdesivir has been included as an "investigational therapy" only for restricted emergency use on COVID-19 patients.
Read More
Health Ministry issues fresh clinical management protocol for COVI
Updated : 10 months ago IST
New Delhi [India], June 13 (ANI): The Union Health Ministry issued a fresh clinical management protocol for COVID-19 patients on Saturday. As per the latest protocol, the health ministry has described the use of investigational therapies--Remdesivir, Convalescent plasma, Tocilizumab, and
Read More
Dr Reddy's Labs in licensing pact with Gilead Sciences for Remdesi
Updated : 10 months ago IST
Hyderabad (Telangana) [India], June 13 (ANI): Dr Reddy's Laboratories said on Saturday it has entered into a non-exclusive licensing agreement with Gilead Sciences Inc that will grant Dr Reddy's the right to register, manufacture and sell Gilead's investigational drug Remdesivir, a potent
Read More
India to soon begin domestic production of Remdesivir drug to figh
Updated : 10 months ago IST
New Delhi [India], June 13 (ANI): India is soon going to have its domestic production of anti-viral Remdesivir drug, which would have safety, efficacy and stability for "restricted emergency use" on COVID-19 patients.
Read More
Zydus signs licensing agreement with Gilead to manufacture and mar
Updated : 10 months ago IST
Ahmedabad (Gujarat) [India], June 13 (ANI): Healthcare major Zydus Cadila has signed a non-exclusive licensing agreement with Gilead Sciences Inc for the manufacturing and distribution of Remdesivir, the investigational drug which has been issued an emergency use authorisation by the US Food
Read More
Remdesivir helps to decrease hospital stay, doesn't show benefit i
Updated : 10 months ago IST
New Delhi [India], June 12 (ANI): Remdesivir helps to decrease hospital stay but the benefits don't reflect as far as death or mortality benefit is concerned, All India Institute of Medical Sciences (AIIMS), New Delhi Director Dr Randeep Guleria said on Friday.
Read More
Restricted, emergency use of Remdesivir, Tocilizumab likely for tr
Updated : 10 months, 1 week ago IST
New Delhi [India], June 11 (ANI): Remdesivir, an antiviral drug and Tocilizumab, an immunomodulator, are being considered by the Union Health Ministry for 'restricted, emergency use' and on 'compassionate grounds' to treat severely ill COVID-19 patients.
Read More
'US' current supply of Remdesivir to get exhausted by end of June'
Updated : 10 months, 1 week ago IST
Washington DC [USA], June 8 (ANI): The US government's current supply of Remdesivir, the only drug till now known to be working against coronavirus, will exhaust by the end of June.
Read More
Centre brings fresh rules for import of unapproved new drug for 'c
Updated : 10 months, 1 week ago IST
New Delhi [India], June 8 (ANI): The Union Health Ministry has drafted the new rules for import of unapproved new drug for only 'compassionate Use' for treatment of patients by hospitals or medical institutions under New Drugs and Clinical Trials Rules, 2019.
Read More